[
    "{\n    \"id\": 1,\n    \"drug_name\": \"Acyclovir\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Gluc-NaCl, Hartmann\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging. Do not refrigerate.\",\n    \"pH\": \"11\",\n    \"incompatible_drugs\": [\n        \"aztreonam\",\n        \"cisatracurium\",\n        \"dobutamine\",\n        \"dopamine\",\n        \"foscarnet\",\n        \"levofloxacin\",\n        \"meropenem\",\n        \"morphine sulfate\",\n        \"ondansetron\",\n        \"pantoprazole\",\n        \"pethidine\",\n        \"piperacillin with tazobactam\",\n        \"tramadol\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/mL in D5W- Dextrose 5% \\\\u02df  Aztreonam 40mg/ml in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"A white crystalline needle-like precipitate formed immediately upon mixing. A dense flocculent white precipitate formed by 4 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/mL in D5W- Dextrose 5% \\\\u02df Cistracurium 5mg/mL in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"A white cloudy precipitate appeared immediately in samples.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 5mg/mL in D5W- Dextrose 5%  \\\\u02df Dobutamine 1mg/mL in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Brown cloudiness developed in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 5mg/mL in D5W- Dextrose 5%  \\\\u02df Dopamine 1.6mg/mL in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Color changes to dark brown in 2 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/mL in D5W- Dextrose 5%  \\\\u02df Foscarnet 24mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Crystalline precipitation appeared immediately upon mixing. The crystals were identified as Acyclovir.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/mL in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Foscarnet 24mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Crystalline precipitation appeared immediately upon mixing. The crystals were identified as Acyclovir.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 10mg/mL in Undiluted \\\\u02df Foscarnet 24mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred immediately.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/mL in D5W- Dextrose 5%  \\\\u02df Levofloxacin  5mg/mL in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Tiny white crystals appeared upon mixing becoming large needle-like crystals within 4 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 50mg/mL in Reconstituted solution Undiluted  \\\\u02df Levofloxacin  5mg/mL in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Cloudy precipitation appeared upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 5mg/ml in Sterile water for injection \\\\u02df Meropenem 50mg/ml in NS-Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation developed.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 5mg/ml in D5W- Dextrose 5%  \\\\u02df Meperidine Hydrochloride (Pethidine) 10mg/ml Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White crystalline precipitation developed in 1 Hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/ml in D5W- Dextrose 5%  \\\\u02df Morphine 15mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Gross white precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/ml in D5W- Dextrose 5%  \\\\u02df Ondansetron 1mg/ml in NS-Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 50mg/ml in Reconstituted solution Undiluted \\\\u02df Pantoprazole 4mg/ml in Reconstituted solution Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared within 4 hours after mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Acyclovir 7mg/ml in D5W- Dextrose 5% \\\\u02df Piperacillin-Tazobactam 40 and 5mg/ml in D5W- Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Small particulates not visible in normal light developed in 1 Hour.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 2,\n    \"drug_name\": \"Alteplase\",\n    \"iv_fluid\": \"NaCl 0.9%\",\n    \"storage\": \"Store below 25\\u2103 in original packaging. Protect from light.\",\n    \"pH\": \"4.5-7.5\",\n    \"incompatible_drugs\": [\n        \"bivalirudin\",\n        \"dobutamine\",\n        \"dopamine\",\n        \"glyceryl trinitrate\",\n        \"heparin sodium.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Alteplase 1mg/ml in Reconstituted solution Undiluted \\\\u02df Bivalirudin 5mg/ml in D5W \\\\u2013 F4 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatible\\\",\\n    \\\"reason\\\": \\\"Microaggregates not visible in normal room light appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Alteplase 1mg/ml in Reconstituted solution Undiluted \\\\u02df Dobutamine 8mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Haze detected by spectrophotometry in 20 minutes. Haze and crystals became visible in 2 hours and grew more dense through 6 days.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Alteplase 1mg/ml in Reconstituted solution Undiluted \\\\u02df Dopamine 8mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Haze and trace crystals became visible in 4 hours and became more dense through 6 days.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Alteplase 1mg/ml in Reconstituted solution Undiluted \\\\u02df Heparin 100 units/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Haze and crystals became visible by 24 hours.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 3,\n    \"drug_name\": \"Amikacin\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Hartmann\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging.\",\n    \"pH\": \"3.5-5.5\",\n    \"incompatible_drugs\": [\n        \"amphotericin b\",\n        \"ampicillin\",\n        \"heparin sodium\",\n        \"pantoprazole\",\n        \"phenytoin sodium\",\n        \"propofol\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Amphotericin B Cholesteryl sulphate complex 0.83mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Heavy precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Amphotericin B Conventional colloidal  0.4mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in Dextrose 5% in Sodium Chloride 0.45% \\\\u02df Amphotericin B  Conventional colloidal  0.4mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Amphotericin B  Conventional colloidal  0.4mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02dfAmphotericin B Lipid complex 1mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared and settled to the bottom.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02dfAmphotericin B liposome 1mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Gross precipitation appeared immediately upon mixing, which became a separate layer after 4 hours. Turbidity increased to such a high level it could not be measured.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in D5W \\\\u2013 Dextrose 5%  \\\\u02df Ampicillin 80mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physically compatible but Ampicillin sodium is known to be unstable in dextrose-containing solutions\\\",\\n    \\\"reason\\\": \\\"\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in Dextrose 5% in Sodium Chloride 0.45% \\\\u02df Ampicillin 80mg/ml in Sterile water for injection\\\",\\n    \\\"type\\\": \\\"Physically compatible but Ampicillin sodium is known to be unstable in dextrose-containing solutions\\\",\\n    \\\"reason\\\": \\\"\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Heparin 160mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9% \\\\u02df Heparin 160mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Heparin 160mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 250mg/ml in Undiluted \\\\u02df Pantoprazole 4mg/ml in Reconstituted solution undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Phenytoin sodium 25mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in Dextrose 5% in Sodium chloride 0.45%\\\\u02df Phenytoin sodium 25mg/ml in Dextrose 5% in Sodium chloride 0.45%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in Dextrose 5% in Sodium chloride 0.9%  \\\\u02df Phenytoin sodium 25mg/ml in Dextrose 5% in Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically compatible\\\",\\n    \\\"reason\\\": \\\"No changes in measured haze or turbidity, particulates, or color were found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 20mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Phenytoin sodium 25mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 5mg/ml in D5W \\\\u2013 Dextrose 5%\\\\u02dfPropofol 10mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Disrupted emulsion appeared soon after mixing with creaming and precipitation forming in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Amikacin 50mg/ml in Undiluted \\\\u02dfPropofol 10mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Visible changes to emulsion integrity. Substantial changes in measured zeta potential and in fat globule size.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 4,\n    \"drug_name\": \"Aminophylline\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Hartmann\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging. Protect from light. Do not freeze. Discard ampoule if contents discoloured.\",\n    \"pH\": \"8.6-10\",\n    \"incompatible_drugs\": [\n        \"amiodarone\",\n        \"ciprofloxacin\",\n        \"cisatracurium\",\n        \"clarithromycin\",\n        \"dobutamine\",\n        \"hydralazine\",\n        \"ondansetron.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 5mg/ml  in D5W \\\\u2013 Dextrose 5% \\\\u02df Amiodarone 4mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Visible haze developed in 15 minutes and became a white precipitate by 6 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 5mg/ml  in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Amiodarone 4mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Visible haze developed in 15 minutes and became a white precipitate by 6 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 2mg/ml  in D5W \\\\u2013 Dextrose 5% \\\\u02df Ciprofloxacin  2mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Small white crystals appeared in 20 minutes.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 2mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Ciprofloxacin  2mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Small white crystals appeared in 20 minutes\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 2.5mg/ml in D5W-Dextrose 5% \\\\u02df Cisatracurium 5mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Gray low-level haze not visible in normal room light developed in 1 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline  2mg/ml  in D5W-Dextrose 5% \\\\u02df Clarithromycin 4mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Crystals formed in 2 hours at 30 \\\\u2103 and in 4 hours at 17 \\\\u2103.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 4mg/ml in D5W \\\\u2013 Dextrose 5%  \\\\u02df Dobutamine 4mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Hazy precipitation and color change appeared in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline  4mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Dobutamine 4mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Hazy precipitation and color change appeared in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Dobutamine 6.25mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml  in Dextrose 5% in Sodium Chloride 0.45% and 0.9% \\\\u02df Dobutamine 6.25mg/ml in  Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml in  NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Dobutamine 6.25mg/ml in  NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 2.5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Ondansetron 1mg/ml in NS-Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Turbid precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Ondansetron 1mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Physical incompatibility. An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9% \\\\u02df Ondansetron  1mg/ml  in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Physical incompatibility. An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 12.5mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Ondansetron  1mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Physical incompatibility. An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 2mg/ml in D5W-Dextrose 5% \\\\u02df Hydralazine 0.16mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"A yellow discoloration appeared in the samples.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Aminophylline 4mg/ml in D5W-Dextrose 5% \\\\u02df Hydralazine 1mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Substantial color change occurred in 1 hour.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 5,\n    \"drug_name\": \"Dexamethasone\",\n    \"iv_fluid\": \"NaCl 0.9% Gluc 5%, Hartmann\\u2019s, Ringer\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging. Do not freeze.\",\n    \"pH\": \"7-8.5\",\n    \"incompatible_drugs\": [\n        \"ciprofloxacin\",\n        \"midazolam\",\n        \"vancomycin\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"- Dexamethasone 4mg/ml in Undiluted \\\\u02df Ciprofloxacin 2mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Transient white haziness appears and then dissipates upon mixing. White crystalline precipitation developed in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 4mg/ml in Undiluted \\\\u02df Ciprofloxacin 2mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Transient white haziness appears and then dissipates upon mixing. White crystalline precipitation developed in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 4mg/ml in Undiluted \\\\u02df Midazolam 1mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Haziness appeared immediately upon mixing. Precipitation developed in 8 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 4mg/ml in Undiluted   \\\\u02df Midazolam 5mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 12mg/ml in D5W \\\\u2013 Dextrose 5% \\\\u02df Midazolam 2.5mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 12mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\\u02df Midazolam 2.5mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Dexamethasone 12mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Midazolam 2.5mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 6,\n    \"drug_name\": \"Digoxin\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Hartmann\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging\",\n    \"pH\": \"6.7-7.3\",\n    \"incompatible_drugs\": [\n        \"amiodarone\",\n        \"amphotericin\",\n        \"fluconazole\",\n        \"foscarnet\",\n        \"insulin (soluble)\",\n        \"propofol.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.25mg/ml in Undiluted +  Amiodarone 3mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White opaque precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.25mg/ml in Undiluted + Amiodarone 6mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Opaque white cloudiness appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.25mg/ml in Undiluted  + Amphotericin B Cholesteryl sulphate complex 0.83mg/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Microprecipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.125mg/ml in D5W \\\\u2013 Dextrose 5% + Amphotericin B Conventional colloidal 0.4mg/ml in D5W \\\\u2013 Dextrose 5% , Dextrose 5% in Sodium Chloride 0.45% and 0.9% , NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.125mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9% + Amphotericin B Conventional colloidal 0.4mg/ml in Dextrose 5% in Sodium Chloride 0.45% and 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.125mg/ml in  NS \\\\u2013 Sodium Chloride 0.9% + Amphotericin B Conventional colloidal 0.4mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.25mg/ml in Undiluted + Amphotericin B Liposome in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"A decrease in measured turbidity from the normal turbidity level appeared within 4 hours after mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.005mg/ml in D5W \\\\u2013 Dextrose 5%  + Insulin 1 Unit/ml in D5W \\\\u2013 Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Slight haziness developed in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Digoxin 0.25mg/ml in Undiluted + Propofol 10mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Emulsion damage with free oil formation occurred.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 7,\n    \"drug_name\": \"Fosphenytoin\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%\",\n    \"storage\": \"Store between 2 and 8_x0002_\\u2103  in original packaging\",\n    \"pH\": \"8.6-9.0\",\n    \"incompatible_drugs\": [\n        \"drotrecogin alfa (activated)\",\n        \"midazolam.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Fosphenytoin 0.1mg/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Drotrecogin alfa (activated) 20mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically compatible\\\",\\n    \\\"reason\\\": \\\"Uncertain chemical stability. The pH of the mixture (8.3) is outside the normal pH range for drotrecogin alfa (activated) of 5.6 to 6.4 . However, no analyses were performed on the samples to determine the actual stability of either of the drugs.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fosphenytoin 1mgPE/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Midazolam 2mg/ml in NS \\\\u2013 Sodium Chloride 0.9%]\\\",\\n    \\\"type\\\": \\\"Physical Incompatible\\\",\\n    \\\"reason\\\": \\\"Midazolam precipitated immediately upon mixing.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 8,\n    \"drug_name\": \"Furosemide\",\n    \"iv_fluid\": \"NaCl 0.9%\",\n    \"storage\": \"Store below 25 \\u2103_x0002_ in original packaging\",\n    \"pH\": \"8-9.3\",\n    \"incompatible_drugs\": [\n        \"adrenaline (epinephrine)\",\n        \"amiodarone\",\n        \"ciprofloxacin\",\n        \"cisatracurium\",\n        \"clarithromycin\",\n        \"diazepam\",\n        \"dobutamine\",\n        \"dopamine\",\n        \"doxapram\",\n        \"drotrecogin\\nalfa (activated)\",\n        \"erythromycin lactobionate\",\n        \"esmolol\",\n        \"fluconazole\",\n        \"gentamicin\",\n        \"hydralazine\",\n        \"labetalol\",\n        \"metoclopramide\",\n        \"midazolam\",\n        \"noradrenaline (norepinephrine)\",\n        \"ondansetron\",\n        \"pantoprazole\",\n        \"vasopressin\",\n        \"vecuronium.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted \\\\u02df Ciprofloxacin 2mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 3mg/ml in D5W-Dextrose 5%   \\\\u02df Cisatracurium 2mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White cloudy precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 3mg/ml  in D5W-Dextrose 5%   \\\\u02df Cisatracurium 5mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White cloudy precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Cisatracurium 5mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Visible turbidity and particulates and change in absorbance were reported.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in D5W-Dextrose 5%   \\\\u02df Clarithromycin 4mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White cloudiness appeared immediately and became white precipitation in 15 minutes.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 1mg/ml D5W-Dextrose 5%   \\\\u02df Dobutamine 4mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Slight precipitation developed in 1 hour.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted \\\\u02df  Dobutamine 4mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted  \\\\u02df Dobutamine 5mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Turbid precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in D5W-Dextrose 5%   \\\\u02df Dobutamine 6.25mg/ml  in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted \\\\u02df                                                     Dopamine 3.2mg/ml in D5W-Dextrose 5%  {Room temperature of 27\\\\u2103 exposed to fluorescent light}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation developed in 4 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in UNdiluted \\\\u02df Dopamine 3.2mg/ml D5W-Dextrose 5%   {Room temperature of 25\\\\u2103}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Turbidity formed within 4 hours after mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 2.5mg/ml in D5W-Dextrose 5% \\\\u02dfDiazepam 5mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 2.5mg/ml in in Dextrose 5% in Sodium Chloride 0.45%  \\\\u02df Diazepam 5mg/ml in Dextrose 5% in Sodium Chloride 0.45%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in Dextrose 5% in Sodium Chloride 0.9%  \\\\u02df Diazepam 2.5mg/ml in Dextrose 5% in Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in NS \\\\u2013 Sodium Chloride 0.9% \\\\u02df Diazepam 2.5mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted     \\\\u02df Esmolol 10mg/ml in D5W-Dextrose 5%  {Room temperature of 21\\\\u2103 exposed to light}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"White cloudiness  appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted  \\\\u02df Esmolol 10mg/ml in NS-Sodium chloride 0.9%  {Near body temperature}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"The infusion pump administering hydrochloride generated an occlusion alarm due to precipitation.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in D5W-Dextrose 5%  \\\\u02df Esmolol 40mg/ml in D5W-Dextrose 5% {Ambient room temperature near 23\\\\u2103 exposed to normal fluorescent light}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in Dextrose 5% in Sodium Chloride  \\\\u02df Esmolol 40mg/ml in Dextrose 5% in Sodium Chloride  {Ambient room temperature near 23\\\\u2103 exposed to normal fluorescent light}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in  NS \\\\u2013 Sodium Chloride \\\\u02df Esmolol 40mg/ml in  NS \\\\u2013 Sodium Chloride {Ambient room temperature near 23\\\\u2103 exposed to normal fluorescent light}\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted \\\\u02df  Fluconazole 2mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation developed in an unspecified time period.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in D5W-Dextrose 5% \\\\u02df Gentamicin 6.4mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in Dextrose 5% in Sodium Chloride \\\\u02df Gentamicin 6.4mg/ml in Dextrose 5% in Sodium Chloride\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 10mg/ml in Undiluted \\\\u02df Gentamicin 10mg/ml in Undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Precipitation  appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in D5W-Dextrose 5%  \\\\u02df Labetalol 2.5mg/ml  in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5mg/ml in Dextrose 5% in Sodium Chloride   \\\\u02df Labetalol 2.5mg/ml in Dextrose 5% in Sodium Chloride\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 2.5 mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Midazolam 1mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"Visible precipitation of furosemide appeared upon contacting the other solutions when using the standard set and the VET+M set at all furosemide concentrations and delivery rates. \\\\nContainer Y-site administration evaluated.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5 mg/ml in D5W-Dextrose 5%\\\\u02df Midazolam 2.5mg/ml in D5W-Dextrose 5%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Furosemide 5 mg/ml in NS \\\\u2013 Sodium Chloride 0.9%  \\\\u02df Midazolam 2.5mg/ml in NS \\\\u2013 Sodium Chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a colour change was found.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 9,\n    \"drug_name\": \"Ganciclovir\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Hartmann\\u2019s Ringer\\u2019s\",\n    \"storage\": \"Store below 30\\u2103  in original packaging.\",\n    \"pH\": \"11\",\n    \"incompatible_drugs\": [\n        \"aztreonam\",\n        \"foscarnet\",\n        \"ondansetron\",\n        \"piperacillin with tazobactam.\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 10,\n    \"drug_name\": \"Gentamicin\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Gluc-NaCl\",\n    \"storage\": \"Store below 25 \\u2103 in original packaging. Do not freeze or refrigerate. Vials are intended for single use only -- discard any unused solution.\",\n    \"pH\": \"3-5.5\",\n    \"incompatible_drugs\": [\n        \"amphotericin\",\n        \"ampicillin\",\n        \"cefradine\",\n        \"drotrecogin alfa (activated)\",\n        \"flucloxacillin\",\n        \"furosemide\",\n        \"heparin sodium\",\n        \"propofol\",\n        \"\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 11,\n    \"drug_name\": \"Paracetamol\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%\",\n    \"storage\": \"Store below 25 \\u2103 , in original packaging.\",\n    \"pH\": \"5.5\",\n    \"incompatible_drugs\": [\n        \"diazepam\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Paracetamol 10mg/ml + Diazepam 5mg/ml\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Discoloration,turbidity,haze, visual particulate matter or precipitation.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Paracetamol 10mg/ml in undiluted  + Diazepam 5mg/ml in undiluted\\\",\\n    \\\"type\\\": \\\"Physical incompatibility\\\",\\n    \\\"reason\\\": \\\"gross yellowish-white turbid precipitation appeared immediately upon mixing.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 12,\n    \"drug_name\": \"Amiodarone\",\n    \"iv_fluid\": \"Gluc 5% (including added KCl)\",\n    \"storage\": \"Store below 25\\u2103 in original packaging.\",\n    \"pH\": \"4\",\n    \"incompatible_drugs\": [\n        \"aminophylline\",\n        \"bivalirudin\",\n        \"digoxin\",\n        \"drotrecogin alfa (activated)\",\n        \"furosemide\",\n        \"heparin sodium\",\n        \"imipenem with cilastatin\",\n        \"magnesium sulfate\",\n        \"micafungin\",\n        \"pantoprazole\",\n        \"piperacillin with tazobactam\",\n        \"sodium bicarbonate\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 13,\n    \"drug_name\": \"Ampicillin\",\n    \"iv_fluid\": \"NaCl 0.9% (including added KCl)\",\n    \"storage\": \"Store below 25\\u2103\",\n    \"pH\": \"8 to 10\",\n    \"incompatible_drugs\": [\n        \"sodium bicarbonate\",\n        \"amikacin\",\n        \"amphotericin\",\n        \"calcium gluconate\",\n        \"dopamine\",\n        \"erythromycin lactobionate\",\n        \"fluconazole\",\n        \"gentamicin\",\n        \"hydralazine\",\n        \"hydrocortisone sodium succinate\",\n        \"metoclopramide\",\n        \"midazolam\",\n        \"ondansetron\",\n        \"tobramycin\",\n        \"verapamil.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity and particulates was found. \\\\n\\\\n- Fluconazole 2mg/ml in Undiluted + Ampicillin 20mg/ml in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Hydralazine 1mg/ml in Dextrose 5% in water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Colour changed by 1 hour.\\\\n\\\\n- Ampicillin 40mg/ml in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Haze and precipitate appeared.\\\\n\\\\n- Midazolam 1mg/ml Dextrose 5% in water + Ampicillin 20mg/ml in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"White precipitation appeared.\\\\n\\\\n- Ondansetron 1mg/ml NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"A milky white precipitation occurred immediately upon mixing and remained throughout the study, Chemical stability \\\\u2013 HPLC analysis found a 91% reduction of the verapamil concentration due to precipitation.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 14,\n    \"drug_name\": \"Anidulafungin\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%\",\n    \"storage\": \"Store at 2-8\\u2103 in original packaging. Do not freeze\",\n    \"pH\": \"3.5-5.5\",\n    \"incompatible_drugs\": [\n        \"sodium bicarbonate. amphotericin.\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 15,\n    \"drug_name\": \"Atropine\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5% (with added KCl)\",\n    \"storage\": \"Store below 25\\u2103 in original packaging. Do not freeze\",\n    \"pH\": \"3-6.5\",\n    \"incompatible_drugs\": [\n        \"pantoprazole.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Atropine 0.4mg/ml in Undiluted + Pantoprazole 4mg/ml in Reconstituted solution, undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 16,\n    \"drug_name\": \"Aztreonam\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Gluc-NaCl, Hartmann\\u2019s, Ringer\\u2019s (all including added KCl)\",\n    \"storage\": \"Store below 25\\u2103 in original packaging.\",\n    \"pH\": \"4.5-7.5\",\n    \"incompatible_drugs\": [\n        \"aciclovir\",\n        \"amphotericin b\",\n        \"ampicillin\",\n        \"ganciclovir\",\n        \"metronidazole\",\n        \"vancomycin.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"A white granular precipitate formed immediately upon mixing of the two drugs in the line.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 17,\n    \"drug_name\": \"Bumetanide\",\n    \"iv_fluid\": \"Gluc 5%, NaCl 0.9%, Gluc-NaCl, Hartmann\\u2019s\",\n    \"storage\": \"Store below 25\\u2103 in original packaging.\",\n    \"pH\": \"7\",\n    \"incompatible_drugs\": [\n        \"midazolam\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 18,\n    \"drug_name\": \"Calcium chloride 10%\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Gluc-NaCl\",\n    \"storage\": \"Store below 25\\u2103 in original packaging.\",\n    \"pH\": \"5 to 8\",\n    \"incompatible_drugs\": [\n        \"sodium bicarbonate\",\n        \"phosphates\",\n        \"amphotericin.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 19,\n    \"drug_name\": \"Esmolol hydrochloride\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Gluc-NaCl, Hartmann\\u2019s (all with added KC\",\n    \"storage\": \"Store below 25 \\u2103 in original packaging. Do not refrigerate or freeze.\",\n    \"pH\": \"4.5-5.5\",\n    \"incompatible_drugs\": [\n        \"amphotericin\",\n        \"diazepam\",\n        \"furosemide.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Furosemide 10mg/mL in Undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"The infusion pump administering esmolol hydrochloride generated an occlusion alarm due to precipitation.\\\\n\\\\n- Esmolol Hydrochloride 10mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Furosemide 10mg/mL in Undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"White cloudiness appeared immediately.\\\\n\\\\n- Esmolol Hydrochloride 10mg/mL in NS\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 20,\n    \"drug_name\": \"Fentanyl\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5% (both with added KCl)\",\n    \"storage\": \"Store below 25 \\u2103 in original packaging. Controlled Drug.\",\n    \"pH\": \"4-7.5\",\n    \"incompatible_drugs\": [\n        \"azithromycin\",\n        \"phenytoin sodium.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Whitish-yellow microcrystalline precipitation appeared on the filters.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fentanyl Citrate 0.025mg/mL (25 mcg/mL)  in Dextrose 5% in sodium chloride 0.9% + Phenytoin Sodium 25mg/mL in Dextrose 5% in sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\\n\\\\n- Fentanyl Citrate 0.025mg/mL (25 mcg/mL) in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred within 1 hours after mixing.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 21,\n    \"drug_name\": \"Fluconazole\",\n    \"iv_fluid\": \"NaCl 0.9%, Gluc 5%, Hartmann\\u2019s, Ringer\\u2019s (all including added KCl)\",\n    \"storage\": \"Store below 25 \\u2103 in original packaging. Do not freeze.\\nInfusions are single use only -discard any unused portion.\",\n    \"pH\": \"4-8 in NaCl 0.9%\",\n    \"incompatible_drugs\": [\n        \"amphotericin\",\n        \"ampicillin\",\n        \"calcium gluconate\",\n        \"cefotaxime\",\n        \"ceftazidime\",\n        \"ceftriaxone\",\n        \"chloramphenicol sodium succinate\",\n        \"clindamycin phosphate\",\n        \"digoxin\",\n        \"furosemide\",\n        \"imipenem with cilastatin\",\n        \"piperacillin\",\n        \"ticarcillin\",\n        \"trimethoprim- sulfamethoxazole\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Amphotericin B 0.4mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\\n\\\\n\\\\n- Fluconazole  2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Amphotericin B 0.4mg/mL in Dextrose 5% in sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\\n\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Amphotericin B 0.4mg/mL in Dextrose 5% in sodium chloride 0.45%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation appeared.\\\\n\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Cloudy precipitation formed.\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Ampicillin Sodium 80mg/mL in Sterile water for injection\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity and particulates was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole  2mg/mL in Undiluted + Calcium Gluconate 100mg/mL in Undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Cloudiness developed in the samples.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole  2mg/mL in Undiluted + Cefotaxime Sodium  20mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Cloudiness and amber colour developed in an unspecified time period.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Ceftazidime 20mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Ceftriaxone Sodium  40mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Chloramphenicol Sodium Succinate 20mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Evolution of a gas was observed.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Furosemide 10mg/mL in Undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation developed in an unspecified time period.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Piperacillin Sodium 80mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"A jelly-like material developed in an unspecified time period.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Fluconazole 2mg/mL in Undiluted + Ticarcillin Disodium 15mg/mL in Unspecified\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"A jelly-like material developed in an unspecified time period\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Sulfamethoxazole-Trimethoprim 20and 4 mg/mL in Dextrose 5% in sodium chloride 0.45%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured turbidity and precipitation appeared.\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured turbidity and precipitation appeared.\\\\n\\\\n- Fluconazole  2mg/mL in NS\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Sodium chloride 0.9% + Sulfamethoxazole-Trimethoprim 20and 4 mg/mL in Dextrose 5% in sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured turbidity and precipitation appeared.\\\\n\\\\n\\\\n- Fluconazole 2mg/mL in NS\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 22,\n    \"drug_name\": \"Famotidine\",\n    \"iv_fluid\": \"D5W, D10W, NS, and Dex/AA solutions\",\n    \"storage\": \"2 to 8\",\n    \"pH\": \"4-5.3\",\n    \"incompatible_drugs\": [\n        \"azithromycin\",\n        \"cefepime and piperacillin/tazobactam.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Famotidine  2mg/mL + Azithromycin 2mg/mL in Normal saline- Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Greyish-white microcrystalline precipitation appeared on the filter.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Famotidine 2mg/mL in Dextrose 5% in Water + Cefepime Hydrochloride 20mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Haziness appeared immediately upon mixing, and flocculent precipitation developed in 4 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Famotidine 2mg/mL in Dextrose 5% in Water + Piperacillin Sodium -Tazobactam Sodium 40and 5 mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Particulates appeared immediately upon mixing.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 23,\n    \"drug_name\": \"Heparin\",\n    \"iv_fluid\": \"D5W, D10W, NS, and \\u00bd NS.\",\n    \"storage\": \"Store below 25 \\u2103 in original packaging. In use: Vial contents should be used within 28 days of first use\",\n    \"pH\": \"5 - 7.5\",\n    \"incompatible_drugs\": [\n        \"alteplase\",\n        \"amikacin\",\n        \"amiodarone\",\n        \"caspofungin\",\n        \"diazepam\",\n        \"gentamicin\",\n        \"netilmicin\",\n        \"phenytoin\",\n        \"tobramycin\",\n        \"and vancomycin.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Heparin Sodium 100units/mL in Dextrose 5% in Water + Alteplase, Recombinant 1mg/mL in Reconstituted solution, undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Haze and crystals became visible by 24 hours .\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 24,\n    \"drug_name\": \"Hydralazine hydrochloride\",\n    \"iv_fluid\": \"NaCl 0.9%, Hartmann\\u2019s, Ringer\\u2019s (all with added KCl)\",\n    \"storage\": \"Store below 30 \\u2103 in original packaging.\",\n    \"pH\": \"3.5 - 4.2\",\n    \"incompatible_drugs\": [\n        \"aminophylline\",\n        \"ampicillin\",\n        \"diazoxide\",\n        \"furosemide\",\n        \"phenobarbital sodium.\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 25,\n    \"drug_name\": \"Imipenem with cilastatin\",\n    \"iv_fluid\": \"D5W, D10W, and NS.\",\n    \"storage\": \"Store below 25\\u2103  in original packaging\",\n    \"pH\": \"6.5 - 7.5\",\n    \"incompatible_drugs\": [\n        \"amikacin\",\n        \"amiodarone\",\n        \"azithromycin\",\n        \"fluconazole\",\n        \"gentamicin\",\n        \"lorazepam\",\n        \"milrinone\",\n        \"sodium bicarbonate\",\n        \"and tobramycin.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium  5mg/mL in Normal saline- Sodium chloride 0.9% + Amiodarone Hydrochloride 3mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Dense white opaque precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium  5mg/mL in Dextrose 5% in Water + Amiodarone Hydrochloride  6mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"White haziness appeared immediately upon mixing. Yellow colour developed over 24 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium 5mg/mL in Normal saline- Sodium chloride 0.9% + Azithromycin  2mg/mL in Normal saline- Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"White microcrystalline precipitation appeared on the filters.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium  10mg/mL in Normal saline- Sodium chloride 0.9% + Fluconazole  2mg/mLin Undiluted\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium 5mg/mL in Normal saline- Sodium chloride 0.9% + Lorazepam  0.33mg/mL in Normal saline- Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow precipitation developed in 24 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Imipenem-Cilastatin Sodium 5mg/mL in Normal saline- Sodium chloride 0.9% + Milrinone Lactate  0.2mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Yellow colour darkening observed in 4 hours.\\\"\\n}\"\n    ]\n}",
    "{\n    \"id\": 26,\n    \"drug_name\": \"Indomethacin\",\n    \"iv_fluid\": \"D2.5W, D5W, and NS.\",\n    \"storage\": \"Store at 20 - 25  \\u2103 and protect from light.\",\n    \"pH\": \"1.2 - 1.5\",\n    \"incompatible_drugs\": [\n        \"calcium gluconate\",\n        \"cimetidine\",\n        \"dobutamine\",\n        \"dopamine\",\n        \"gentamicin\",\n        \"and tobramycin.\"\n    ],\n    \"type_of_incompatibility\": []\n}",
    "{\n    \"id\": 27,\n    \"drug_name\": \"insulin\",\n    \"iv_fluid\": \"D5W, and D10W, and NS.\",\n    \"storage\": \"Store at 2- 8 \\u2103  in original packaging. Do not freeze.\",\n    \"pH\": \"7 - 7.8\",\n    \"incompatible_drugs\": [\n        \"aminophylline\",\n        \"dopamine\",\n        \"micafungin\",\n        \"nafcillin\",\n        \"phenobarbital\",\n        \"and phenytoin.\"\n    ],\n    \"type_of_incompatibility\": [\n        \"{\\n    \\\"dose\\\": \\\"- Insulin human regular 50 units/ml in dextrose 5% in sodium chloride 0.9% + Dopamine hydrochloride 12.8 mg/ml in dextrose 5% in sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or as color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin Human  50units/mL in Dextrose 5% in water + Dopamine hydrochloride 12.8mg/mL in Dextrose 5% in water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"An increase in measured haze or turbidity, particulates, and/or a color change was found.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin human regular 1unit/ml in normal saline- sodium chloride 0.9% + Micafungin sodium 1.5mg/ml in normal saline- sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Microparticulates appeared and the measure haze level increased within 4 hours.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin human regular 0.2unit/ml in Normal saline- sodium chloride 0.9 % + Nafcillin  40mg/ml in dextrose 5% in water\\\",\\n    \\\"type\\\": \\\"Physically incompatible Precipitation appeared immediately upon mixing\\\",\\n    \\\"reason\\\": \\\"\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin human regular 0.2 unit/ ml in Normal saline-sodium chloride 0.9% + Nafcillin 20mg/ml in dextrose 5% in water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation appeared immediately upon mixing.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin Human Regular 50units/mL in Dextrose 5% in Water + Phenytoin Sodium 25mg/mL in Dextrose 5% in Water\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin Human Regular 50units/mL in Dextrose 5% in sodium chloride 0.45% + Phenytoin Sodium 25mg/mL in Dextrose 5% in sodium chloride 0.45%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin Human Regular 50units/mL in Dextrose 5% in sodium chloride 0.9% + Phenytoin Sodium 25mg/mL in Dextrose 5% in sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\",\n        \"{\\n    \\\"dose\\\": \\\"Insulin Human Regular  50units/mL in Normal saline- Sodium chloride 0.9% + Phenytoin Sodium- 25mg/mL in Normal saline- Sodium chloride 0.9%\\\",\\n    \\\"type\\\": \\\"Physically incompatible\\\",\\n    \\\"reason\\\": \\\"Precipitation occurred.\\\"\\n}\"\n    ]\n}"
]